PYRAZINDERIVAT

European patent · EP3144306 · Deleted

Register entry

Publication number
EP3144306
Application number
EP15792266
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
May 12, 2015
Published
Mar 22, 2017
Granted
Nov 15, 2017
Deleted
May 31, 2019
Reason
Annual fee unpaid
IPC classes
C07D 403/04 (2006.01)
A61K 31/497 (2006.01)
A61P 3/10 (2006.01)
A61P 9/10 (2006.01)
A61P 9/12 (2006.01)
A61P 13/12 (2006.01)
A61P 19/06 (2006.01)
A61P 43/00 (2006.01)
C07D 403/14 (2006.01)
C07D 409/14 (2006.01)
Priority
JP 2014099677 13.05.2014
PCT application
PCT/JP2015/063654 12.05.2015
PCT publication
WO2015/174417 19.11.2015
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 18, 2019

    Deleted, fee unpaid

    Published in Swissreg on 18.12.2019

  2. Feb 17, 2018

    Agent entered

    Representative
    Bugnion S.A., Case postale 375, 1211 Genève 12 - Champel

    Published in Swissreg on 17.02.2018

  3. Nov 15, 2017

    Granted

    Published in Swissreg on 15.11.2017

Parties

Holder

Teijin Pharma Limited

2-1, Kasumigaseki 3-chome Chiyoda-ku, Tokyo 100-0013, JP

Agent

Bugnion SA

Bugnion S.A.

Case postale 375, 1211 Genève 12 - Champel

Inventor

MARUYAMA, Akinobu

Tokyo 100-0013, JP

TAKEUCHI, Susumu

Tokyo 100-0013, JP

TAKAHASHI, Yoshimasa

Tokyo 100-0013, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.